Considering Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial

Abstract

Keywords

acute coronary syndromes unstable angina anti-platelet therapy clopidogrel diabetes.

Get full access to this article

View all access options for this article.

References

CAPRIE Steering Committee ; A randomised, blinded trial of Clopidogrel versus Aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.

Bhatt DL , Bertrand ME , Berger PB et al. Meta-Analysis of Randomised and Registry Comparisons of Ticlopidine with Clopidogrel After Stenting; J Am Coll Cardiol 2002;39:9-14.

The Clopidogrel in Unstable angina to prevent Recurrent Events programme ; Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000;21:2033-41.

Pursuit trial investigators ; Inhibition of platelet glycoprotein IIB/IIIA with Eptifibatide in patients with Acute Coronary Syndromes. N Engl J Med 1998;339:436-48.

Simoons ML and the GUSTO IV-ACS Investigators ; Effect of Glycoprotein IIB/IIIA receptor blocker Abciximab on outcome in patients with Acute Coronary Syndrome without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 2001 ;357:1915-24.

Antithrombotic Trialists' Collaboration ; Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction and stroke in high risk patients . BMJ 2002;324:71-86.

The Clopidogrel in Unstable angina to prevent Recurrent Events trial Investigators ; Effects of pretreatment with clopidogrel and aspirin followed by long term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.